{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:13:40Z","timestamp":1788286420488,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Genetics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.tig.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T08:32:58Z","timestamp":1605342778000},"page":"433-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Germline Variants That Affect Tumor Progression"],"prefix":"10.1016","volume":"37","author":[{"given":"Ajay","family":"Chatrath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakrosh","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindya","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tig.2020.10.005_bb0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tig.2020.10.005_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tig.2020.10.005_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41571-018-0002-6","article-title":"The emerging clinical relevance of genomics in cancer medicine","volume":"15","author":"Berger","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tig.2020.10.005_bb0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41598-019-57080-9","article-title":"Challenges in reporting pathogenic\/potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels","volume":"10","author":"Chirita-Emandi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tig.2020.10.005_bb0025","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrc.2017.82","article-title":"Genome-wide association studies of cancer: current insights and future perspectives","volume":"17","author":"Sud","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tig.2020.10.005_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.tig.2020.10.005_bb0035","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tig.2020.10.005_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.gde.2010.04.016","article-title":"Rare genetic variants and the risk of cancer","volume":"20","author":"Bodmer","year":"2010","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.tig.2020.10.005_bb0045","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.28725","article-title":"The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non-small cell lung cancer","volume":"120","author":"Zhao","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.tig.2020.10.005_bb0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tig.2020.10.005_bb0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-16-1045","article-title":"Interaction landscape of inherited polymorphisms with somatic events in cancer","volume":"7","author":"Carter","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tig.2020.10.005_bb0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature12981","article-title":"Realizing the promise of cancer predisposition genes","volume":"505","author":"Rahman","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tig.2020.10.005_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tig.2020.10.005_bb0070","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1038\/ncomms4156","article-title":"Integrated analysis of germline and somatic variants in ovarian cancer","volume":"5","author":"Kanchi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2020.10.005_bb0075","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2020.10.005_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms","volume":"41","author":"Kilpivaara","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2020.10.005_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng0409-385","article-title":"Somatic and germline genetics at the JAK2 locus","volume":"41","author":"Campbell","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2020.10.005_bb0090","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Olcaydu","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2020.10.005_bb0095","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1158\/0008-5472.CAN-10-2689","article-title":"Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.tig.2020.10.005_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tig.2020.10.005_bb0105","doi-asserted-by":"crossref","first-page":"4168784","DOI":"10.1155\/2019\/4168784","article-title":"Mapping the germline and somatic mutation interaction landscape in indolent and aggressive prostate cancers","volume":"2019","author":"Mamidi","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.tig.2020.10.005_bb0110","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.bbadis.2018.01.007","article-title":"Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes","volume":"1864","author":"Yu","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.tig.2020.10.005_bb0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tig.2019.04.005","article-title":"Germline variants impact somatic events during tumorigenesis","volume":"35","author":"Ramroop","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.tig.2020.10.005_bb0120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1158\/1541-7786.MCR-18-0996","article-title":"The germline variants rs61757955 and rs34988193 are predictive of survival in lower grade glioma patients","volume":"17","author":"Chatrath","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.tig.2020.10.005_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tig.2020.10.005_bb0130","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.mayocp.2017.09.001","article-title":"Pharmacogenomics: precision medicine and drug response","volume":"92","author":"Weinshilboum","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.tig.2020.10.005_bb0135","first-page":"65","article-title":"Pharmacogenetics: a general review on progress to date","volume":"124","author":"Daly","year":"2017","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.tig.2020.10.005_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-030-24100-1_4","article-title":"Design and implementing pharmacogenomics study in cancer","volume":"1168","author":"Romero Lagunes","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tig.2020.10.005_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tig.2020.10.005_bb0150","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2020.10.005_bb0155","first-page":"735","article-title":"Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives","volume":"16","author":"Battaglin","year":"2018","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.tig.2020.10.005_bb0160","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1373\/clinchem.2019.303644","article-title":"Biomarkers for predicting response to immunotherapy with immune checkpoint inhibitors in cancer patients","volume":"65","author":"Duffy","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tig.2020.10.005_bb0165","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s12325-019-01051-z","article-title":"Existing and emerging biomarkers for immune checkpoint immunotherapy in solid tumors","volume":"36","author":"Arora","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.tig.2020.10.005_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2019.09.024","article-title":"Comprehensive analysis of colorectal cancer-risk loci and survival outcome: a prognostic role for CDH1 variants","volume":"124","author":"Summers","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tig.2020.10.005_bb0175","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/CMR.0000000000000578","article-title":"Melanoma susceptibility variant rs869330 in the MTAP gene is associated with melanoma outcome","volume":"29","author":"Marasigan","year":"2019","journal-title":"Melanoma Res."},{"key":"10.1016\/j.tig.2020.10.005_bb0180","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/carcin\/bgy021","article-title":"Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome","volume":"39","author":"Shu","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tig.2020.10.005_bb0185","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.21873\/anticanres.11545","article-title":"Cancer stem cell gene variants in CD44 predict outcome in stage II and stage III colon cancer patients","volume":"37","author":"Stotz","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tig.2020.10.005_bb0190","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1158\/1078-0432.CCR-15-1746","article-title":"Association between GWAS-derived rs966423 genetic variant and overall mortality in patients with differentiated thyroid cancer","volume":"22","author":"\u015awierniak","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tig.2020.10.005_bb0195","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/ijc.24120","article-title":"Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer","volume":"124","author":"Koessler","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tig.2020.10.005_bb0200","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12885-019-5628-y","article-title":"The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution","volume":"19","author":"Mosquera Orgueira","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tig.2020.10.005_bb0205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bjh.15521","article-title":"Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients","volume":"183","author":"Macauda","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tig.2020.10.005_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13073-020-0718-7","article-title":"The pan-cancer landscape of prognostic germline variants in 10,582 patients","volume":"12","author":"Chatrath","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.tig.2020.10.005_bb0215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2020.10.005_bb0220","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fgene.2019.00754","article-title":"The cancer-associated genetic variant rs3903072 modulates immune cells in the tumor microenvironment","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.tig.2020.10.005_bb0225","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1073\/pnas.1114759108","article-title":"Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants","volume":"108","author":"Park","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2020.10.005_bb0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2019.11.019","article-title":"Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: a systematic review and case report analysis","volume":"156","author":"Le Page","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tig.2020.10.005_bb0235","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1038\/s41467-019-12071-2","article-title":"Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes","volume":"10","author":"Musa","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2020.10.005_bb0240","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0038-1668516","article-title":"Tumor to cerebellar peduncle T2-weighted imaging intensity ratio fails to predict pituitary adenoma consistency","volume":"80","author":"Mastorakos","year":"2019","journal-title":"J. Neurol. Surg. B Skull Base"},{"key":"10.1016\/j.tig.2020.10.005_bb0245","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tig.2020.10.005_bb0250","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1038\/ncomms10086","article-title":"Patterns and functional implications of rare germline variants across 12 cancer types","volume":"6","author":"Lu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2020.10.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181725","article-title":"IL-6 variant is associated with metastasis in breast cancer patients","volume":"12","author":"Abana","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tig.2020.10.005_bb0260","doi-asserted-by":"crossref","first-page":"E11701","DOI":"10.1073\/pnas.1804506115","article-title":"Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration","volume":"115","author":"Lim","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952520302948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952520302948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:09:57Z","timestamp":1759190997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168952520302948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0168952520302948"],"URL":"https:\/\/doi.org\/10.1016\/j.tig.2020.10.005","relation":{},"ISSN":["0168-9525"],"issn-type":[{"value":"0168-9525","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline Variants That Affect Tumor Progression","name":"articletitle","label":"Article Title"},{"value":"Trends in Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tig.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}